FDA approved expanded use of Gardasil 9 vaccine to include adults 27 through 45 years old
On Oct. 5, 2018, the FDA announced it had approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to include women and men aged 27 through 45 years.
Gardasil 9 prevents certain cancers and diseases caused by the nine HPV types covered by the vaccine.
Tags:
Source: U.S. Food and Drug Administration
Credit:
